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Sodium modeling in hemodiafiltration. A computer model was devel-
oped to simulate sodium and water kinetics during hemodiafiltration
(HDF), acetate-free biofiltration (AFB) and hemodialysis (HD). Multi-
ple regression analysis of the results of 3,240 simulated applications of
the model (1,620 HDF, 1,080 AFB, 540 HD) showed that, during HDF
and AFB, there is a close correlation (R2 = 0.92 and 0.91) between
plasma water sodium concentration ([NaPl) and a set of three varia-
bles: 1) the sodium gradient between plasma water and dialysate, 2) the
sodium concentration of the substitution fluid and 3) ultrafiltration (UF)
rate. With HD, a close correlation (R2 = 0.94) was found between
changes in [NaP] and combined changes in sodium gradient and the
UF rate. On this basis, a regression equation was formulated for each
procedure which allowed a reliable prediction of final [NaP] to be
made on the basis of knowledge of the imposed Na gradient, the
programmed infusion (during HDF and AFB), and the UF rate. Clinical
validation of the model was obtained in 12 patients: predicted final
[NaP1 agreed well with the values measured by means of direct
potentiometry (141.9 vs. 142.1 mEq/liter; P = NS), with a mean
difference (—0.16 mEq/liter) and limits of agreement (+0.8 to —1.03
mEq/liter) fully acceptable for clinical purposes. During HD, isonatric-
ity was maintained by imposing a mean sodium gradient of 6.8 mEqI
liter, whereas, during HDF and AFB, (HDF performed with infusion of
49 to 66 mI/mm of a solution containing 140 to 145 mEq/liter of Na, and
AFB with a solution containing 145 or 167 mEq/liter of Na infused at the
rate of 28.5 to 41 mI/mm) the mean gradients required to avoid [NaP]
changes were 9.5 and 14.6 mEq/liter, respectively. The sodium infused
with the substitution fluid, and the Donnan effect related to the high
imposed UF rates, led to progressive sodium retention, which had to be
counterbalanced by diffusion, increasing the transrnembrane sodium
gradient, in order to reach the target sodium and water balance and
reduce the risk of untoward cardiovascular side-effects.
In confirmation of kinetic (1—6] and clinical studies [7—9], the
clinical application of computer based sodium models [3, 10—12]
has been shown to improve cardiovascular stability and reduce
the morbidity due to inadequate sodium and water removal
during hemodialysis (HD). These models permit computation of
the dialysate sodium concentration ([NaD]) necessary to mod-
ulate sodium transfer by diffusion, in order to optimize net
solute and water removal according to individual needs and
reach target end-dialysis plasma water sodium concentrations
([NaF]).
However, such models are not applicable to hemodiafiltration
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therapy (HDF). The variable concentrations and rates of the
sodium and water infused with the substitution fluid modify the
plasma water sodium concentration available for diffusion and
convection, and has significant effects on the dynamics of
sodium flux across the dialyzer membrane and on the net cation
transfer. Lack of awareness of this phenomenon implies the
possibility of serious errors in mass balance during treatment
and the risk of either immediate or delayed cardiovascular
side-effects.
The aim of the present study was to try to characterize the
nature of sodium transfer during HDF and acetate-free biofil-
tration (AFB). A model was developed which predicts changes
in plasma water sodium concentrations and net transfer of
solute during the treatment, due to the use of different dialysate
sodium concentrations and substitution fluids with variable
sodium content and infusion rate.
Methods
The model
The theoretical premises for sodium modeling in HD therapy,
based on the principles of fluid dynamics [13], have been
extensively reported by Sargent and Gotch [1] and Kimura et al
[3]. Model assumptions may be summarized as follows:
(1) With respect to osmotic equilibrium, total body water
(TBW), coextensive with urea distribution volume (V), can be
described as a two compartment system (VI = intracellular
water, VE extracellular water) [1].
V VI + VE (1)
(2) The absolute amount of intracellular effective osmoles,
which do not cross the cell membrane, is constant [3, 13]. In
this view the mass balance equation for the total effective
osmoles in VI in the time interval from ti to t2 is:
VI(t2) x CI(t2) — VI(tl) x CI(tl) = 0 (2)
where CI(t) is the effective osmolality in VI at any time t.
(3) Equilibrium is maintained between CI(t) and the effective
osmolality in yE, CE(t), because of the high fluid permeability
of the cell membranes.
CI(t) = CE(t) (3)
In fact, any change in CE(t) is followed by a transcellular fluid
shift resulting in re-equilibrium of the effective osmolality in the
two compartments at the expense of VI.
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(4) Only sodium and its accompanying anions are assumed to
be effective osmotic substances in VE [1, 31.
According to the above assumptions, in post-dilution HDF
the fluid balance equation in the time interval from ti to t2 is:
V(t2) — V(tl) — (Qs — Quf) x (t2 — tI)
where Qs and Quf (liter/mm) are the fluid infusion and ultrafil-
tration (UF) rates, respectively.
In the same time interval, the mass balance equation for the
extracellular effective osmoles, which do not cross the cell
membrane, may be written as:
VE(t2) x CE(t2) — VE(tl) x CE(tl) Qs(t2 — tI) x CS
+Dx(t2—tl)x[CD—CE(tl)]—Quf(t2—tl)xCE(+ 1)
where CS and CD are the effective osmolalities in substitution
fluid and dialysate, respectively, and D is diffusive dialysance,
or the rate per minute of net transfer of effective osmoles by
diffusion across the dialyzer membrane per unit of dialysate-
plasma water gradient.
Equation 5 indicates that the change in the extracellular
content of effective osmoles over the period t 1 to t2 is the sum
of the solute infusion flux (first term on the right), diffusion
transfer across the membrane (second term) and convective
removal (third term).
As a consequence of assumption 4, there is a close relation-
ship between effective osmolality in VE and plasma water
sodium concentration ([NaP]) [3]:
CE — [Na + P] x r x k (6a)
where r is the Donnan factor for sodium, and k is the osmotic
coefficient for sodium chloride that converts concentration to
effective osmolality.
Similarly, the relationship between effective osmolality and
sodium concentrations in dialysate and substitution fluid
([NaD] and [NaPS], respectively) may be formulated as:
CD = [Na + D] x k
CS = [Na ÷ Sj x k
Given the above premises, and the knowledge that sodium is
distributed in VE but its osmotic power extends to TBW, single
pool kinetics is assumed for the cation. The constant amount of
effective osmoles in VI allows changes in body sodium content
from time tl to t2 to be calculated as changes in the product of
[NaP] corrected for r, and the volume V of TBW, where the
osmotic power of sodium is exerted.
Therefore, the mass balance equation for sodium is the sum
of equations 2 and 5 after substituting CE and CI, CD, and CS
by equations 6a, b, and c, respectively:
V(t2) x [Na + P(t2)] x r — V(tl) x [Na P(tl)] x r =
Qs x (t2 — tI) x [Na ÷ S]
+ Dx (t2—tl) x {[NaDI— [NaP(t1)I x r}
— Quf x (t2 — tI) x [Na + P(tl)] x r
TBW liters
(4) Na I mEqiliterNal NaD
mEqiliter
Na dialysance liters/mmNa S mEqlliter
HDF
AFB
HD
UF rate mI/mm
HDF
AFB
HD
td mm
(5) body wt kg/session
Qs mI/mm
HDF
AFB
HD
Dependent variable: Nat
According to the stepwise regression procedure 115. 161 only one of
a set of multicollinear independent variables was included in the
statistical analysis. Therefore, of the independent variables that corre-
lated with each other [UF rate, fluid infusion rate (Qs), rate of body
weight loss and treatment time (td)], only UF rate was included, since
it contributed more than the others to the prediction of[Na' P1 changes
during the treatment. Four different UF rates, resulting from the
reported combined variations of td. Qs and body weight loss, were
considered for each set of the other parameters. The total number of
simulated sessions was 3240 (1620 HDF, 1080 AFB and 540 HD).
The assumed constant (k) is present on both sides of the
equation and factors out.
Solution of equation 4 for V(t2) with known values of V(tl),
Qs and Quf, and of equation 7 for [NaP(t2)] with known values
of [NaP(t1)], [NaD], and [NatS], D and r, respectively,
provide the volume of distribution and sodium concentration
values at the end of period tI to t2. If the conditions at the
(6b) beginning of the treatment are known, the iteration of calcula-tions at equal intervals of time over the entire length of
'6 treatment (td) allows the changes in [NatP] related to each setc, of clinical and treatment parameters to be predicted. Vice-
versa, the solution of equation 7 for [NaD] allows the dialysate
sodium concentration necessary to obtain a given final sodium
concentration to be calculated. The model can be applied to HD
treatment by setting the substitution fluid infusion rate at zero.
Statistical evaluation
HDF, AFB and HD were simulated in a hypothetical patient
under various operational conditions, obtained by varying the
clinical and treatment parameters within the ranges commonly
observed in clinical practice (Table I). Only the Donnan factor
was kept constant (r = 0.95) at a value corresponding to the
mean measured value in previous studies of ours [2, 5] and of
others l2, 14]. A computed multiple 1oop developed 18,360
possible combinations of parameters, each corresponding to a
treatment session. This led to the generation of redundant and
overlapping information which unnecessarily complicated data
analysis. Therefore, only four different UF rates, resulting from
(7) selected combined variations in the amount of infusion, body
Table 1. Treatment parameters in the computer simulation study
Range of variation No. of
Independent variables From To Step values
30 45 7.5 3
136 148 6 3
5 +15 5 5
0.1 0.3 0.1 3
140 150 5 3
145 167 22 2
37.5
29.2
4.2
150
86.7
61.1
20.1
240
3
16.4
10.8
5.3
4
4
4
33.3 66.6
25 41.7
F — Nat I
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Table 2. Treatment and clinical parameters in patient studies
Treatment
(No. of
sessions) Patient
Studied
sessions
No.
Age
years
TBW
liters
td
mm
Range of
body wt
kg
Na s
mEqi
liter
QS
Range of
Quf
mi/mm
•Filter
Membrane m2
D Na
liter!
mm
HDF(37) I 8 25 39 210 1—3 140 65 69.8—79.3 PSF 1.8 0.160
2 10 32 26 150 1.6—2.7 142 50 60.7—68.7 PSF 1.8 0.148
3 8 46 30 180 2.3—3 140 66 70.5—81.5 PAN 1.6 0.135
4 Ii 36 26 180 0.7—2.8 145 48.8 61.6—66.7 PAN 1.6 0.130
AFB (37) 5 9 28 30.5 180 1.2—2.6 167 32 38.9—46.7 PAN 1.2 0.126
6 Ii 42 25.5 180 0—2.2 145 41 41.0—54.2 PAN 1.6 0.145
7 8 51 27 150 1.9—2.5 167 33 45.7—49.7 PAN 1.2 0.130
8 9 56 31.5 210 1.6—2.2 167 28.5 36.1—39.0 PAN 1.2 0.121
HD (31) 9 7 46 38 240 2.0—3.3 — — 8.3—13.8 CUP 1.5 0.100
10 8 38 30 165 1.4—2.7 — — 8.5—16.4 CUP 1.5 0.125
ii 7 54 27.5 180 1.1—2.3 — — 6.1—12.8 CUP 1.5 0.100
12 9 59 35 210 0.8—2.3 — — 3.8—11.0 CUP 1.5 0.115
Blood flow rate was 350 18 mI/mm; dialysate flow rate was 500 32 mI/mm.
Abbreviations not specified in the text are: PSF, polysulfone; PAN, polyacrylonitrile; CUP, cuprophane.
weight loss and length of treatment, were considered per
session. This procedure yielded a total of 3240 well-defined
treatment sessions (1620 HDF, 1080 AFB and 540 HD) which
simulated most real clinical settings. Equations 4 and 7 were
iteratively solved with the aid of a computer program for every
minute of the duration of each treatment session, and the
[NaF) predicted by the model for each session was recorded.
Stepwise multiple regression analysis, as well as analysis of
variance and covariance [15, 161 were applied to the results of
the simulated treatments in order to assess the reliability of the
model and to determine which, or which set, of the considered
independent variables (treatment parameters) was statistically
important in [NaF] prediction.
Clinical evaluation
Twelve stable uremic, non-diabetic patients on chronic re-
placement therapy with HDF (4 patients), AFB (4 patients) and
HD (4 patients) were studied.
Pilot treatment sessions were performed at least three times
in each patient with the same dialyzer and under the same
operational conditions as those of the study, During these
sessions, urea distribution volume (as an estimate of TBW) was
determined in each patient by means of the dialysate collection
method of urea kinetics [17] and equilibrated end-treatment
urea concentration values [18—20]. In addition, the mean diffu-
sive sodium dialysance of each pilot session was estimated by
monitoring initial [NaPI, inlet [NaD], [NaPS], body weight
loss, and UF and infusion rates; net sodium removal was
quantified from the dialysate side (total sodium content of the
collected spent dialysate minus total sodium content of inlet
dialysate minus total sodium content of the substitution fluid).
These values were substituted for the left term in equation 7,
which was solved for D over a time interval equal to the length
of the session. The mean values of sodium dialysance obtained
for each patient during the pilot sessions were taken as a
constant treatment parameter for model predictions.
Each patient was then studied during a mean of 10 treatment
sessions, performed using the same operational parameters as
in the pilot studies (dialyzer, blood and dialysate flow, length of
treatment, sodium concentration and infusion rate of the sub-
stitution fluid). Body weight loss and the set UF rate of each
session were recorded, as well as initial and equilibrated final
[NaP] and inlet [NaD] (every hour).
As shown in Table 2, all of the variations in values fell within
the ranges established by the simulation study.
Each determination of plasma and inlet dialysate sodium used
to measure the sodium gradient, and thus, in the model, to
predict solute transfer by diffusion, was made in triplicate by
means of ion-selective electrode (ISE) (Stat Profile 4, Nova
Biomedical). This method provides direct measurement of
sodium activity [21] in the plasma water and dialysate streams,
and thus a correct measure of the driving force for diffusive
sodium flux across the dialyzer [6, 22, 23]. Net sodium removal
was quantified from the dialysate side as in the pilot studies: for
mass balance calculations sodium concentrations in the replace-
ment solution, the inlet and in the spent dialysate were mea-
sured using a flame photometer (IL 943, Instruments Labora-
tory) to detect the total (ionized plus anion-bound) sodium
concentration of these fluids, and thus net changes in total body
sodium content [22].
Infusion of exogenous osmotically active substances was
avoided during the study.
Data from 105 sessions (37 HDF, 37 AFB, 31 HD) were
available for statistical analysis after the data relative to the 16
sessions in which blood and dialysate sodium mass balance
differed by more than 10% were discarded.
Measured [NaF] values and net sodium removal were
compared with those predicted by the model (the solution of
equation 7, according to the procedure specified in the previous
section). As suggested by Bland and Altman [24], analysis of
accuracy and error of the predictions was performed by calcu-
lating the mean difference (d) between actual and predicted
values, the 95% confidence interval of the bias, the standard
deviation (s) and the "limits of agreement" (d + 2s and d — 2s),
and by plotting the differences between measured and predicted
[NaF1 values against their means.
Correlation coefficients between the error in prediction and
actual treatment parameters were determined in order to estab-
lish whether the methodology involved any systematic errors.
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Full-fledged model Y1
R2
Table 3. Results of the computer simulation studies: Stepwise multiple regression analysis
1-IDF (No. — 1620) AFB (No. — 1080) HD (No. = 540)
___________________ -
partial r partial t partial r partial t partial r
0.97 119.9 —0.96 —95.4 —0.97
0.51 32.2 0.70 — —
0.47 19.9 0.52 8.7 0.32
0.33 7.6 —0.23 —1.5 —0.07
—0.029 14.9 0.38 1.9 —0.08
0 0 0 0 0
F test
SE of regression 1.1 1.1
Shortened model Y1_3
R2 0.922 0.909 0.944
F test 6367 3582 4526
SE of regression 1.2 1.3 1.0
The regression equations of the shortened models are presented in the text. Partial r and t are t statistics and correlation coefficients of each
independent variable.
Results
Simulation study
Stepwise multiple regression and analysis of variance, ap-
plied separately to the results of the three simulated procedures
(Table 3), identified a set of three independent variables as a
good predictor of changes in [NaP] during HDF and AFB: 1)
the sodium concentration gradient between initial plasma water
([NaI]) and dialysate fluid; 2) the sodium concentration of the
substitution fluid; and 3) the imposed UF rate. Similarly,
analysis of the simulated HD results showed a close relation-
ship between the changes in [NaPJ during treatment and the
combined changes in sodium diffusion gradient and the rate of
UF.
The other independent variables considered (sodium dialy-
sance, initial plasma sodium concentration, and the volume of
TBW) were excluded during the stepwise procedure; they did
not make any significant additive contribution to predicting
changes in [NaPJ (evaluated as the decrease in the sum of the
squares for error induced by including, one by one, each
variable in the relation). In fact, the squared coefficients of
multiple regression of the full-fledged models (0.94, 0.93 and
0.94 on HDF, AFB and HD, respectively) were close to those
of the shortened three-variable regression equations for HDF
and AFB (0.92 and 0.91, respectively) and of the two-variable
equation for HD (0.94). In both cases, this demonstrates a good
fit of the regression equations to the simulated treatment data,
with only a negligible reduction in the predictive power of the
shortened in comparison with the full-fledged models.
On this basis, the following three equations were formulated:
[HDF] NaF—Na1 = —19.3
—0.41 (NaI —NaD)
+0.15 (NaS)+0,03 Quf
[AFB] Na*F —NaI = —13.4— 0,41 (NaI —NaD)
+0.1 NaS+0.05Quf
[HD] Na F Na + I = 2.6 — 0.46 (Na I — Na + D)
+ 0.02 Quf
These equations allow changes in [NaP] over the treatment
period to be predicted on the basis of only readily available
treatment parameters.
The need for different regression equations was shown by
means of the multiple regression analysis of the combined
results of the three simulated procedures (3,240 data), coded by
dummy variables to evaluate the interaction effects of each
procedure with the independent variables predicting [NaPj:
sodium gradient, fNaS] and UF rate [15, 161, The squared
coefficient of multiple correlations which did not take interac-
tions into account, changed significantly when interactions
were considered (R2 = 0.911 and 0.936, respectively; F test
value = 32.1, P <0.001). Equivalent to the F test of the analysis
of covariance [161, this test revealed a significant difference in
the slopes of the three regression lines, thus demonstrating the
existence of interactions between the procedures and the inde-
pendent variables. The same analysis of the combined results of
simulated HDF and AFB also showed significant differences (F
— 21.2) in the slopes of the regression equations for these two
procedures.
Clinical results
The results of the clinical application of the model, by
procedure, are reported in Table 4; mean measured values for
[NaF] and net sodium removal did not differ significantly from
those predicted by the full-fledged model on the basis of
individually set clinical and operational parameters (as specified
in Table 2), or by the solution of the regression equations of the
shortened models (equations 8, 9, 10). More important from the
practical point of view is the agreement shown between mea-
sured [NaFJ values and those predicted by the shortened
models (Fig. I): differences were normally distributed and the
mean difference was —0.16 mEq/liter, with a 95% confidence
interval for bias of from —0.03 to 0.29 mEq/liter (a mean
percent deviation of predicted from actual values of —0.11%
0.10%). The plotting of individual differences in measured and
predicted values against their means showed a homogeneous
distribution of points within the limits of agreement (+ 1.14 and
—1.46 mEq/liter with respect to the mean measured value).
(10) These limits are small enough to make the degree of agreement
I Na I — Na D mEqlliter
2 Na S mEqi/iter
3 UF rate rn//mm
4 Na I mEqiliter
5 D Na liter/pnin
6 V liter
partial
—157.4
23.7
21.9
—16.1
—13.6
0
0.937
3998
0.930
2375
0.945
1835
0.9
(8)
(9)
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Table 4. Results of the clinical application of the model
HDF AFB HD Total
(37 (37 (31 (105
sessions) sessions) sessions) sessions)
Na I mEqiliter
Mean SD 142.5 2.1 143.6 2.0 141.7 2.6 142.6 2.4
Range 139.2—146.4 138.2—147.1 136.0—146.0 136.0—147.1
Na I — Na D
Mean SD 9.5 2.2 17.1 2.7 6.8 3.0 11.4 5.1
Range 6.0—12.4 8.5—21.3 —1—13.6 —1—21.3
Na F mEqiliter
Measured 142.6 1.5 142.1 1.4 141.7 1.7 142.1 1.5
Predicted by 142.4 1.6 141.9 1.6 141.5 1.7 141.9 1.6
model
Predicted by 142.3 1.9 141.9 1.8 141.5 1.6 141.9 1.8
equation
Na balance
mEq
Measured —318 86 —267 122 —305 93 —296 103
Predicted by —324 85 —272 130 —309 93 —301 107
model
Na F and Na balances are presented as means SD. P = NS
between measured values and those predicted by the full-fledged model
or by the solution of regression equations 8, 9, and 10 of the shortened
models.
acceptable for clinical purposes and the predictions reliable. In
fact, the percent error of prediction was +0.8% to —1.03% of
actual [NaF] values.
Error in the predictions did not correlate with actual values
for [NaF] (r = 0,09, t = 0.8), or with the other clinical and
operational parameters (V, body weight loss, Qs, Quf, D and
actual transmembrane sodium gradient). Only [NaI] corre-
lated with the difference in actual and predicted fNaF] (r =
0,21) but this correlation was slightly under the level of signif-
icance (t = 1.89, vs. t005 = 1.98).
Comparison of initial and final [NaP] values (Table 4)
showed that, in agreement with model predictions, a mean
imposed transmembrane gradient of 6.8 mEq/liter allowed
isonatricity to be maintained during HD; on HDF, when sub-
stitution fluid containing 140 to 145 mEq/liter of sodium was
infused at a rate of 49 to 66 mi/mm, no changes in [NaP] were
observed with a mean gradient of 9.5 mEq/liter. During AFB,
performed in 26 out of 37 sessions with an infusion of a solution
containing 167 mEq/liter of sodium, a slight fall in [NaPI, in
accordance with the predictions, was observed as an effect of a
mean sodium gradient of 17.1 mEq/liter, about 2.5 mEq/liter
higher than that predicted by the model to maintain isonatricity.
Discussion
A body of evidence demonstrates the importance of an
adequate salt and water balance during dialysis in improving
cardiovascular stability during treatment and preventing the
risk of pulmonary edema and uncontrolled hypertension due to
sodium and water overload [7—9, 25—28]. This risk is even
greater during high efficiency treatments and when strategies
coupling diffusion with convection are adopted. In fact, during
HDF and AFB, the sodium content of the substitution fluid may
affect sodium concentration in plasma water and modify its net
transfer across the dialyzer membrane. The application of
kinetic models to dialysis therapy enhances the possibility of
Turther reducing this dialysis-related morbidity [3, 11, 12] by
allowing a prediction of the dialysate sodium concentration
necessary to obtain the target individual sodium and water
removal. It therefore seemed important to develop a kinetic
model capable of predicting and modulating water and sodium
removal during extracorporeal substitution fluid infusion treat-
ments, such as HDF and AFB, while taking into account the
different kinetics of the solute during these procedures.
To formulate a model suitable for clinical application, the
events influencing the kinetics of the modeled solute during
extracorporeal treatment need to be simplified. In modeling
sodium in HDF, as in HD models, the choice of a single pool
was based on the osmotic distribution of the cation in TBW,
thus ensuring the equilibrium of effective osmolality across the
cell membrane by means of fluid shifts driven by changes in
extracellular osmolality. The assumed constant amount of
effective osmoles within the cells and the close relationship
between [NaPI and CE allow changes in body sodium content
during the treatment to be calculated from the difference
between the products of TBW volume and [NaP] at the
beginning and end of the session. However, the typically steady
state theoretical assumptions of the model do not always hold
true during treatment. Delayed solute diffusion from the cells
leads to a transcellular concentration gradient and, possibly, a
transient osmotic effect which drives fluid into the cells [I].
Fluid transfer between compartments may also occur indepen-
dently of sodium whenever other osmotic substances (such as
mannitol or glucose) are rapidly ad(led to or removed from
extracellular space. These events may affect the value of the
final sodium concentration measured immediately after the end
of treatment, and thus invalidate sodium balance calculations
based on a single pool analysis which assumes osmotic TBW
equilibrium. Model-predicted [NaF] should correspond to the
value measured after the completion of post-treatment inter-
compartmental re-equilibration. It is frr this reason that, in this
study, the measured [NaF] concentrations in our patients
refer to equilibrated samples taken 30 minutes after the end of
the treatment sessions [19, 20].
Stepwise regression analysis of the results of the computer
simulation studies showed that changes in plasma water sodium
concentration during HDF and AFB were closely related to
three well-defined treatment parameters: the sodium concentra-
tion gradient across the dialyzer membrane, the imposed UF
rate and the sodium concentration of the substitution fluid. A
similar relationship was found during HD between [NaP]
changes and the first two treatment parameters. Simulated
treatment data best fitted the regression lines for each single
procedure, and so the solution of the model regression equa-
tions should allow final plasma sodium concentrations to be
predicted reliably on the basis of only the imposed transmem-
brane sodium gradient, the programmed infusion (during HDF
and AFB) and the rate of UF. It is not necessary to know any
of the other patient or dialyzer parameters, or to consider any of
the interactions among variables, which would complicate
clinical application of the model. Vice-versa, solution of the
regression equations in terms of sodium gradient should allow a
prediction of the dialysate sodium concentration needed to
remove a target amount of sodium, thus permitting the desired
final sodium concentration to be reached.
The results of the clinical application of the model in 12
patients undergoing different extracorporeal treatments (HD,
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137 138 139 140 141 142 143 144 145 146 147
Average predicted and measured NaF, mEqi/iter
HDF and AFB) confirmed the reliability of the full-fledged
model (with clinical and operational parameters individually
set). In addition, actual [NaFI values did not differ signifi-
cantly from those predicted by the solution of the regression
equations of the three-variable model for HDF and AFB, or of
the two-variable model for RD. Combined data from the three
procedures showed a mean percent difference between pre-
dicted and actual [NaFj values of 0.11%, with 95% of the
predicted values lying within the limits of agreement; a differ-
ence which is small enough to be considered acceptable for
clinical purposes (+0.8% to —1.03% of the mean actual value).
These results confirm the accuracy of the proposed algorithm
and the reliability of the predictions which can be obtained
using the shortened models, which may prove useful in achiev-
ing adequate sodium and water removal during extracorporeal
treatment. The small range of error seems to be more than
compensated for by the immediate availability of the prediction,
which only requires the measurement of initial plasma water
sodium concentration. This simplified approach, which retains
the validity of the single pool analysis of sodium transport on
which it is based, avoids the need for the more cumbersome
calculations of other patient and treatment parameters (such as,
sodium dialysance, TBW volume, mass transfer coefficients)
that full-fledged single pool or two pool analyses require for
practical use.
The methodology used in in plasma and dialysis fluid sodium
measurements requires deeper insight into its clinical implica-
tions.
Bosch et al have stressed the need to determine the true
sodium concentration gradient across the membrane, when
studying sodium transfer during hemodialysis [6]. In that study
active plasma water sodium concentration was defined as the
photometrically measured plasma sodium concentration, cor-
rected by the volume of hydrated plasma proteins, minus the
amount of sodium complexed (mainly with the proteins) [29,
30], which thus no longer contributes to the ionic activity of
Fig. 1. Differences in predicted and actual
[NaFJ values for each session plotted against
their means. Dashed lines represent the 95%
confidence intervals of mean differences and the
limits of agreement (mean 2 SD). Symbols
are: (0) HDF; (+) AFB; (*) HD.
plasma water [31]. Sodium activity in plasma water can be
directly measured by potentiometry [21], without the need for
the proposed calculations [321.
However, the negatively-charged plasma proteins exert an
additive electrical effect on sodium ions (the Donnan effect),
which leads to a corresponding amount of sodium ions being
retained in the acqueous phase of the bloodstream. These ions
are not available for diffusion, even if they are dissociated in
plasma water. Hence, both calculated and directly-measured
active plasma water sodium concentrations should be corrected
for the Donnan factor in order to obtain the concentration of
sodium available for diffusion [6].
On the other side of the membrane, Stiller and Mann [33]
observed significant differences in sodium measurements per-
formed with flame photometry and direct potentiometry in
dialysis fluid containing acetate or bicarbonate: at the buffer
concentrations used in clinical practice the difference was about
4 mEq/liter (higher with flame photometry). Similar results were
also obtained in one of our studies [23]. Once again this
difference may be explained by the fact that flame photometry
measures total sodium concentration, irrespective of ionization;
potentiometry, which measures sodium ionic activity and does
not detect sodium complexed with anions, provides a more
correct measurement of the active dialysate sodium concentra-
tion available for diffusion.
In agreement with these findings, Gotch, Evans and Keen
[22] recommend the use of potentiometry in measuring plasma
and dialysis fluid sodium concentration whenever the true
sodium diffusion gradient across the dialyzer membrane must
be determined. However, the same authors stress the need to
take into account total sodium transfers (ionized plus com-
plexed sodium), when sodium mass balance.must be calculated.
In this case the use of flame photometry to measure sodium in
blood (blood side balance) or in dialysis and substitution fluids
(dialysate side balance) is required.
In our HD patients, isonatricity was maintained by imposing
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sis.
Reprint requests to Dr. Luciano Pedrini, Servizio Nefrologia e
Dialisi, Ospedale "S. Isidoro", 24069 Trescore Balneario, Bergamo,
Italy.
Appendix. Glossary
C(t) (mOsmlkg water) Effective osmolality at time t. CI,
CE: effective osmolality in VI and yE. CD, CS:
effective osmolality in dialysate and substitution
fluid.
D (liters/mm) Mean diffusive dialysance of the
[NaP] (mEq/liter) Plasma water sodium concentration.
[Nai], [NaF]: pre-treatment and end-treatment
concentrations.
[NaD] (mEq/liter) Dialysate sodium concentration.
[NaPS] (mEq/liter) Substitution fluid sodium concentration.
(liters/mm) Ultrafiltration rate.
(liters/mm) Substitution fluid infusion rate.
(liters) Total body water volume.
(liters) Urea distribution volume, coextensive with
TBW. VI, VE: intracellular and extracellular
volumes.
k Osmotic coefficient for sodium chloride.
r Donnan factor for sodium.
td (mm) Duration of treatment session.
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